Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL001165

Drug Information
NameBMS-833923
CompanyExelixis / Bristol-Myers Squibb
IndicationCancers
[ICD9: 140-229   ICD10: C00-C96]
Phase Ib    [1]
TargetSmoothenedInhibitor[1]
Ref 12011 Pipeline of Exelixis. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543